000 01266 a2200337 4500
005 20250517080029.0
264 0 _c20170216
008 201702s 0 0 eng d
022 _a1365-2516
024 7 _a10.1111/hae.12888
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMathew, P
245 0 0 _aInhibitors in haemophilia A: a perspective on clotting factor products as a potential contributing factor.
_h[electronic resource]
260 _bHaemophilia : the official journal of the World Federation of Hemophilia
_cMay 2016
300 _a334-41 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAntibodies, Neutralizing
_xblood
650 0 4 _aCoagulants
_ximmunology
650 0 4 _aFactor VIII
_ximmunology
650 0 4 _aHemophilia A
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aProtein Processing, Post-Translational
650 0 4 _aRisk Factors
650 0 4 _avon Willebrand Factor
_xchemistry
700 1 _aDinter, H
700 1 _aChurch, N
700 1 _aHumphries, T J
700 1 _aKulkarni, R
773 0 _tHaemophilia : the official journal of the World Federation of Hemophilia
_gvol. 22
_gno. 3
_gp. 334-41
856 4 0 _uhttps://doi.org/10.1111/hae.12888
_zAvailable from publisher's website
999 _c25700588
_d25700588